Clients

AAA (Advanced Accelerator Applications)

European leader in the production and commercialisation of PET (Positron Emission Tomography) and SPECT (Single Photon Emission Tomography) radiopharmaceuticals and is able to produce and deliver both commercial drugs and research products.

Acobiom (ex-Skuldtech)

Specialized in the discovery of new Biomarkers and the development of innovative Diagnostics focused on personalized medicine applications.

Adebiotech

French association of biotechnology companies. Supported by French ministries, Adebiotech organizes interactions between biotechnology companies to promote and support responsible innovations.

Advanced BioDesign

Advanced BioDesign is a French biotechnology company developing an innovative targeted therapy to treat resistant cancers, with a first indication in acute myeloid leukemia.

Advent France Biotechnology

Advent France Biotechnology focuses on ground-breaking innovations in Life Sciences to address unmet medical and clinical needs, building the next generation of pioneering healthcare companies

Aelix Therapeutics

Biotechnology company focused on the development of a therapeutic HIV vaccine to be used as part of a cure/eradication strategy.

Alaxia

Alaxia, an affiliate of the Stragen Pharma Group, specializes in developing antimicrobial therapies for cystic fibrosis and other chronic respiratory diseases.

Alcoa Fastening Systems

Specialised engineering for the global aerospace, automotive, and commercial transportation markets producing high quality, wide application fastening system solutions.

Alderaan Biotechnology

Alderaan Biotechnology is a preclinical stage company focused on monoclonal antibodies development for the treatment of cancer with technologies aiming at Treg depletion and NK cell modulation.

Alizé Pharma

Group composed of privately-held biopharmaceutical companies specialised in the development of innovative therapeutics for the treatment of metabolic diseases and cancer.

Alize Pharma 3

Alizé Pharma 3 develops innovative therapeutic peptides for rare endocrine and metabolic diseases. Its ambition is to become a leading company in rare diseases with operations in the US and Europe, geared to supporting the global development of products.

Alma Bio Therapeutics

Pioneering a curative approach to treat autoimmune diseases, in particular Crohn’s disease and rheumatoid arthritis.